-
61
Gaps in the management of adrenal insufficiency in melanoma survivors: a retrospective cohort studyResearch in context
Published 2025-01-01Subjects: Get full text
Article -
62
Profile of STING agonist and inhibitor research: a bibliometric analysis
Published 2025-02-01Subjects: Get full text
Article -
63
-
64
Immunotherapeutic Potential of the Yellow Fever Virus Vaccine Strain 17D for Intratumoral Therapy in a Murine Model of Pancreatic Cancer
Published 2025-01-01Subjects: Get full text
Article -
65
Editorial: Community series in adenosine pathways in cancer immunity and immunotherapy, volume II
Published 2025-01-01Subjects: Get full text
Article -
66
-
67
HIFU-CCL19/21 Axis Enhances Dendritic Cell Vaccine Efficacy in the Tumor Microenvironment
Published 2025-01-01Subjects: Get full text
Article -
68
Applications of cell penetrating peptide-based drug delivery system in immunotherapy
Published 2025-01-01Subjects: Get full text
Article -
69
CD32B1, a versatile non-signaling antibody-binding scaffold for enhanced T cell adhesion to tumor stromal cognate antigens
Published 2025-02-01Subjects: “…cancer immunotherapy…”
Get full text
Article -
70
From chaos to order: optimizing fecal microbiota transplantation for enhanced immune checkpoint inhibitors efficacy
Published 2025-12-01Subjects: Get full text
Article -
71
Unlocking the secrets of the immunopeptidome: MHC molecules, ncRNA peptides, and vesicles in immune response
Published 2025-01-01Subjects: Get full text
Article -
72
Identification of TUBB3 as an immunotherapy target in lung cancer by genome wide in vivo CRISPR screening
Published 2025-02-01Subjects: Get full text
Article -
73
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
Published 2025-01-01Subjects: “…Cancer immunotherapy…”
Get full text
Article -
74
A self-activated and protective module enhances the preclinical performance of allogeneic anti-CD70 CAR-T cells
Published 2025-01-01Subjects: Get full text
Article -
75
-
76
-
77
A minimal gene set characterizes TIL specific for diverse tumor antigens across different cancer types
Published 2025-02-01Get full text
Article -
78
-
79
-
80